Research Article: Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer
Introduction:
Lung cancer stands as the most menacing malignant tumor, jeopardizing both human life and health. Its incidence and fatality rates take the forefront among all malignancies, with over % constituting non-small cell lung cancer (NSCLC). Despite ongoing enhancement of therapeutic techniques, radiotherapy often falls short in delivering satisfactory efficacy, resulting in a bleak prognosis. During the treatment of NSCLC patients, the emergence of activated epidermal growth factor receptor (EGFR) mutations holds the…
Read more